Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
CTXR
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w low +47.3%
CTXR
Citius Pharmaceuticals Inc. Common
☁️ News word cloud
Top words across the last 50 articles for this ticker.
nasdaq
trading
market
stocks
after
pharmaceuticals
citius
therapeutics
rose
biotech
announced
nyse
gained
penny
oncology
million
phase
here
june
reported
StonvexStonvexStonvexStonvex